integrin alpha 5/beta 1 (InnoPharmaScreen)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameintegrin alpha 5/beta 1 (InnoPharmaScreen)
Drug Alias NameCD29 antagonist (InnoPharmaScreen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin beta-1 inhibitors
TargetsIntegrin beta-1
Therapy Area/IndicationsNervous System DiseasesNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnoPharmaScreen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnoPharmaScreen Inc
Active IndicationsN/A
Inactive IndicationsNervous System DiseasesNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A